Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $11.60B.
ENTERPRISE VALUE (EV)
$11.60B
Madrigal Pharmaceuticals, Inc.
Market Cap
$11.45B
Enterprise Value (EV)
$11.60B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | $11.45B | $11.60B |
| Bio-Techne Corporation (TECH)vs › | $11.34B | $11.37B |
| DaVita Inc. (DVA)vs › | $11.64B | $21.75B |
| The Cooper Companies, Inc. (COO)vs › | $10.94B | $13.33B |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.82B | $14.15B |
| Twist Bioscience Corporation (TWST)vs › | $10.70B | $10.68B |
| Universal Health Services, Inc. (UHS)vs › | $10.63B | $15.75B |
| Encompass Health Corporation (EHC)vs › | $12.36B | $15.09B |
| ICON Public Limited Company (ICLR)vs › | $12.40B | $14.96B |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.46B | $14.30B |
Market Cap
$11.45B
Total Debt
$347.63M
Cash
$198.69M
Enterprise Value
$11.60B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
